NURS 615 Pharm Exam 1 – Maryville
Questions with Correct Answers 2025
HowBdoesBhypoalbuminemiaBaffectBtheBprocessBofBprescribing?B-BCORRECTBANSWERB-
LowBalbuminB=BmoreBfreeBdrugB(bcBtheBdrugBcan'tBbindBtoBalbuminBakaBprotein)B=BincreasedBadver
seBeffects
WhatBisBaBBlackBBoxBWarning:B-BCORRECTBANSWERB-
isBconsideredBaBcontraindicationBtoBadministerBthatBdrug.
WhatBisBtheBdrugsBhalf-life?B-BCORRECTBANSWERB-Half-
lifeBspecificallyBmeansBtheBamountBofBtimeBitBtakesBforBanBadministeredBdrugBtoBbeBhalfwayBcleare
dBfromBtheBsystem.
PeakBofBaction:B-BCORRECTBANSWERB-
theBtimeBbetweenBdrugBadministrationBandBmaximumBconcentrationBofBdrugBinBtheBbloodBstream.
BBestBtherapeuticBeffect.
DurationBofBaction:B-BCORRECTBANSWERB-
theBtimeBbetweenBonsetBofBactionBandBmetabolismBofBdrugBbelowBtheBminimumBneededBforBanBef
fect.BTheBlengthBofBtimeByouBhaveBtheBdrugBinByourBsystem.
AccordingBtoBtheBWHOBwhatBisBtheBfirstBstepBinBtheBprescribingBprocess?B-BCORRECTBANSWERB-
TheBfirstBstepBisBtoBdefineBtheBpatient'sBproblem
TheBsecondBstepBisBtoB-BCORRECTBANSWERB-specifyBtheBtherapeuticBobjective
TheBthirdBstepBisBtoB-BCORRECTBANSWERB-chooseBwhichBdrugBorBtreatmentBisBneeded.
,StepB4BofBtheBWHOBapproach:B-BCORRECTBANSWERB-StartBtheBtreatment
StepB5BofBtheBWHOBapproach:B-BCORRECTBANSWERB-EducateBtheBpatient
StepB6BofBtheBWHOBapproach:B-BCORRECTBANSWERB-MonitorBtheBtreatment
PhaseB1BofBdrugBdevelopment:B-BCORRECTBANSWERB-TheBdrugBisBtestedBonBhealthyBvolunteers
PhaseB2BofBdrugBdevelopment:B-BCORRECTBANSWERB-
trialsBwithBpeopleBwhoBhaveBtheBdiseaseBforBwhichBtheBdrugBisBthoughtBtoBbeBeffective
PhaseB3BofBdrugBdevelopment:B-BCORRECTBANSWERB-
LargeBnumbersBofBpatientsBinBmedicalBresearchBcentersBreceiveBtheBdrugBinBphaseB3.BThisBlargerBsa
mplingBprovidesBinformationBaboutBinfrequentBorBrareBadverseBeffects.BTheBFFABwillBapproveBaBne
wBdrugBapplicationBifBphaseB3BstudiesBareBsatisfactory.
PhaseB4BofBdrugBdevelopment:B-BCORRECTBANSWERB-
ThisBphaseBisBvoluntaryBandBinvolvesBpostmarketBsurveillanceBofBtheBdrug'sBtherapeuticBeffectsBatB
theBcompletionBofBphaseB3.BTheBpharmaceuticalBcompanyBreceivesBreportsBfromBdoctorsBandBoth
erBhealthBcareBprofessionalsBaboutBtheBtherapeuticBresultsBandBadverseBeffectsBofBtheBdrug.BSome
Bmedications,BforBexample,BhaveBbeenBfoundBtoBbeBtoxicBandBhaveBbeenBremovedBfromBtheBmarke
tBafterBtheirBinitialBrelease.
ExplainBfirstBpassBmetabolismB-BCORRECTBANSWERB-
muchBofBtheBdrugBisBlostBinBtheBabsorptionBprocess.BTheBliverBmetabolizesBmanyBdrugs,BthusBreduc
esBtheBbioavailabiltyBofBtheBdrug.
, WhatBisBtheBfastedBrouteBofBabsorption:B-BCORRECTBANSWERB-
TheBfastestBrouteBofBabsorptionBisBinhalation,BandBnotBasBmistakenlyBconsideredBtheBIVBadministra
tion.
WhyBdoesBtheBGIBtractBtakeBlongerBtoBabsorb?B-BCORRECTBANSWERB-
TheBGIBtractBisBlinedBwithBepithelialBcells;BdrugsBmustBpermeateBthroughBtheseBcellsBinBorderBtoBbe
BabsorbedBintoBtheBcirculatoryBsystem.
WhatBisBOneBparticularBcellularBbarrierBthatBmayBpreventBabsorptionBofBaBgivenBdrug?B-
BCORRECTBANSWERB-
theBcellBmembrane.BCellBmembranesBareBessentiallyBlipidBbilayersBwhichBformBaBsemipermeableB
membrane.BPureBlipidBbilayersBareBgenerallyBpermeableBonlyBtoBsmallBandBunchargedBsolutes,Bhe
nceBwhetherBorBnotBaBmoleculeBisBionizedBwillBaffectBitsBabsorption,BsinceBionicBmoleculesBareBcha
rged.
WhatBisBsolubility?B-BCORRECTBANSWERB-
SolubilityBfavorsBchargedBspecies,BpermeabilityBfavorsBneutralBspecies.BSomeBmoleculesBhaveBspe
cialBexchangeBproteinsBandBchannelsBtoBfacilitateBmovementBfromBtheBlumenBintoBtheBcirculation.
WhyBdoesBabsorptionBoccurBatBaBslowerBrateBforBoral,BIM,BSQBroutes?B-BCORRECTBANSWERB-
AbsorptionBoccursBatBaBslowerBrateBbecauseBtheBcomplexBmembraneBsystemsBofBGIBmucosalBlayer
s,Bmuscle,BandBskinBdelayBdrugBpassage.
TheBabilityBofBaBdrugBtoBcrossBaBcellBmembraneBdependsBon:B-BCORRECTBANSWERB-
whetherBtheBdrugBisBwaterBorBlipidB(fat)Bsoluble.BLipid-
solubleBdrugsBeasilyBcrossBthroughBcellBmembranes;Bwater-solubleBdrugsBcan't.BLipid-
solubleBdrugsBcanBalsoBcrossBtheBblood-brainBbarrierBandBenterBtheBbrain.
AsBaBdrugBtravelsBthroughBtheBbody,BitBcomesBinBcontactBwith?B-BCORRECTBANSWERB-
proteinsBsuchBasBtheBplasmaBproteinBalbumin.BTheBdrugBcanBremainBfreeBorBbindBtoBtheBprotein.BT
heBportionBofBaBdrugBthat'sBboundBtoBaBproteinBisBinactiveBandBcan'tBexertBaBtherapeuticBeffect.BOnl
Questions with Correct Answers 2025
HowBdoesBhypoalbuminemiaBaffectBtheBprocessBofBprescribing?B-BCORRECTBANSWERB-
LowBalbuminB=BmoreBfreeBdrugB(bcBtheBdrugBcan'tBbindBtoBalbuminBakaBprotein)B=BincreasedBadver
seBeffects
WhatBisBaBBlackBBoxBWarning:B-BCORRECTBANSWERB-
isBconsideredBaBcontraindicationBtoBadministerBthatBdrug.
WhatBisBtheBdrugsBhalf-life?B-BCORRECTBANSWERB-Half-
lifeBspecificallyBmeansBtheBamountBofBtimeBitBtakesBforBanBadministeredBdrugBtoBbeBhalfwayBcleare
dBfromBtheBsystem.
PeakBofBaction:B-BCORRECTBANSWERB-
theBtimeBbetweenBdrugBadministrationBandBmaximumBconcentrationBofBdrugBinBtheBbloodBstream.
BBestBtherapeuticBeffect.
DurationBofBaction:B-BCORRECTBANSWERB-
theBtimeBbetweenBonsetBofBactionBandBmetabolismBofBdrugBbelowBtheBminimumBneededBforBanBef
fect.BTheBlengthBofBtimeByouBhaveBtheBdrugBinByourBsystem.
AccordingBtoBtheBWHOBwhatBisBtheBfirstBstepBinBtheBprescribingBprocess?B-BCORRECTBANSWERB-
TheBfirstBstepBisBtoBdefineBtheBpatient'sBproblem
TheBsecondBstepBisBtoB-BCORRECTBANSWERB-specifyBtheBtherapeuticBobjective
TheBthirdBstepBisBtoB-BCORRECTBANSWERB-chooseBwhichBdrugBorBtreatmentBisBneeded.
,StepB4BofBtheBWHOBapproach:B-BCORRECTBANSWERB-StartBtheBtreatment
StepB5BofBtheBWHOBapproach:B-BCORRECTBANSWERB-EducateBtheBpatient
StepB6BofBtheBWHOBapproach:B-BCORRECTBANSWERB-MonitorBtheBtreatment
PhaseB1BofBdrugBdevelopment:B-BCORRECTBANSWERB-TheBdrugBisBtestedBonBhealthyBvolunteers
PhaseB2BofBdrugBdevelopment:B-BCORRECTBANSWERB-
trialsBwithBpeopleBwhoBhaveBtheBdiseaseBforBwhichBtheBdrugBisBthoughtBtoBbeBeffective
PhaseB3BofBdrugBdevelopment:B-BCORRECTBANSWERB-
LargeBnumbersBofBpatientsBinBmedicalBresearchBcentersBreceiveBtheBdrugBinBphaseB3.BThisBlargerBsa
mplingBprovidesBinformationBaboutBinfrequentBorBrareBadverseBeffects.BTheBFFABwillBapproveBaBne
wBdrugBapplicationBifBphaseB3BstudiesBareBsatisfactory.
PhaseB4BofBdrugBdevelopment:B-BCORRECTBANSWERB-
ThisBphaseBisBvoluntaryBandBinvolvesBpostmarketBsurveillanceBofBtheBdrug'sBtherapeuticBeffectsBatB
theBcompletionBofBphaseB3.BTheBpharmaceuticalBcompanyBreceivesBreportsBfromBdoctorsBandBoth
erBhealthBcareBprofessionalsBaboutBtheBtherapeuticBresultsBandBadverseBeffectsBofBtheBdrug.BSome
Bmedications,BforBexample,BhaveBbeenBfoundBtoBbeBtoxicBandBhaveBbeenBremovedBfromBtheBmarke
tBafterBtheirBinitialBrelease.
ExplainBfirstBpassBmetabolismB-BCORRECTBANSWERB-
muchBofBtheBdrugBisBlostBinBtheBabsorptionBprocess.BTheBliverBmetabolizesBmanyBdrugs,BthusBreduc
esBtheBbioavailabiltyBofBtheBdrug.
, WhatBisBtheBfastedBrouteBofBabsorption:B-BCORRECTBANSWERB-
TheBfastestBrouteBofBabsorptionBisBinhalation,BandBnotBasBmistakenlyBconsideredBtheBIVBadministra
tion.
WhyBdoesBtheBGIBtractBtakeBlongerBtoBabsorb?B-BCORRECTBANSWERB-
TheBGIBtractBisBlinedBwithBepithelialBcells;BdrugsBmustBpermeateBthroughBtheseBcellsBinBorderBtoBbe
BabsorbedBintoBtheBcirculatoryBsystem.
WhatBisBOneBparticularBcellularBbarrierBthatBmayBpreventBabsorptionBofBaBgivenBdrug?B-
BCORRECTBANSWERB-
theBcellBmembrane.BCellBmembranesBareBessentiallyBlipidBbilayersBwhichBformBaBsemipermeableB
membrane.BPureBlipidBbilayersBareBgenerallyBpermeableBonlyBtoBsmallBandBunchargedBsolutes,Bhe
nceBwhetherBorBnotBaBmoleculeBisBionizedBwillBaffectBitsBabsorption,BsinceBionicBmoleculesBareBcha
rged.
WhatBisBsolubility?B-BCORRECTBANSWERB-
SolubilityBfavorsBchargedBspecies,BpermeabilityBfavorsBneutralBspecies.BSomeBmoleculesBhaveBspe
cialBexchangeBproteinsBandBchannelsBtoBfacilitateBmovementBfromBtheBlumenBintoBtheBcirculation.
WhyBdoesBabsorptionBoccurBatBaBslowerBrateBforBoral,BIM,BSQBroutes?B-BCORRECTBANSWERB-
AbsorptionBoccursBatBaBslowerBrateBbecauseBtheBcomplexBmembraneBsystemsBofBGIBmucosalBlayer
s,Bmuscle,BandBskinBdelayBdrugBpassage.
TheBabilityBofBaBdrugBtoBcrossBaBcellBmembraneBdependsBon:B-BCORRECTBANSWERB-
whetherBtheBdrugBisBwaterBorBlipidB(fat)Bsoluble.BLipid-
solubleBdrugsBeasilyBcrossBthroughBcellBmembranes;Bwater-solubleBdrugsBcan't.BLipid-
solubleBdrugsBcanBalsoBcrossBtheBblood-brainBbarrierBandBenterBtheBbrain.
AsBaBdrugBtravelsBthroughBtheBbody,BitBcomesBinBcontactBwith?B-BCORRECTBANSWERB-
proteinsBsuchBasBtheBplasmaBproteinBalbumin.BTheBdrugBcanBremainBfreeBorBbindBtoBtheBprotein.BT
heBportionBofBaBdrugBthat'sBboundBtoBaBproteinBisBinactiveBandBcan'tBexertBaBtherapeuticBeffect.BOnl